The distribution of mannose 6-phosphate (Man6P) receptors for lysosomal enzymes was investigated in human normal and mucolipidosis 11 (I-cell) disease fibroblasts by light and electron microscopic immunocytochemistry. In normal fibroblasts whose lysosomal enzymes contain Man6P recognition markers required for binding to the receptor, intracellular immunoreactive receptors were concentrated in one or two cisternae located on one side of the Golgi stack, in coated vesicles, and in lysosomes and endosomes. Presumably, this distribution delineates the Man6P-dependent transport pathway for newly synthesized lysosomal enzymes. In I-cell fibroblasts whose lysosomal enzymes lack the Man6P recognition marker, intracellular receptors were found almost exclusively in one or two Golgi cisternae and in numerous coated vesicles located near the immunoreactive cisternae but were rarely detected in lysosomes and endosomes. The results obtained on I-cell fibroblasts suggest that in the absence of endogenous ligands (lysosomal enzymes bearing Man6P residues), Man6P receptors do not constitutively shuttle-via coated vesicles-between the Golgi complex and lysosomes or endosomes. Rather, they accumulate in coated vesicles concentrated at the presumptive sorting site in the Golgi complex. The findings suggest that a specific subpopulation of coated vesicles (primary lysosomes) is involved in Man6P receptor transport of lysosomal enzymes from the Golgi complex to lysosomes and that their relocation is triggered by ligand binding.
ABSTRACT
The distribution of mannose 6-phosphate (Man6P) receptors for lysosomal enzymes was investigated in human normal and mucolipidosis 11 (I-cell) disease fibroblasts by light and electron microscopic immunocytochemistry. In normal fibroblasts whose lysosomal enzymes contain Man6P recognition markers required for binding to the receptor, intracellular immunoreactive receptors were concentrated in one or two cisternae located on one side of the Golgi stack, in coated vesicles, and in lysosomes and endosomes. Presumably, this distribution delineates the Man6P-dependent transport pathway for newly synthesized lysosomal enzymes. In I-cell fibroblasts whose lysosomal enzymes lack the Man6P recognition marker, intracellular receptors were found almost exclusively in one or two Golgi cisternae and in numerous coated vesicles located near the immunoreactive cisternae but were rarely detected in lysosomes and endosomes. The results obtained on I-cell fibroblasts suggest that in the absence of endogenous ligands (lysosomal enzymes bearing Man6P residues), Man6P receptors do not constitutively shuttle-via coated vesicles-between the Golgi complex and lysosomes or endosomes. Rather, they accumulate in coated vesicles concentrated at the presumptive sorting site in the Golgi complex. The findings suggest that a specific subpopulation of coated vesicles (primary lysosomes) is involved in Man6P receptor transport of lysosomal enzymes from the Golgi complex to lysosomes and that their relocation is triggered by ligand binding.
Considerable evidence indicates that the intracellular sorting of lysosomal enzymes and their delivery to lysosomes is accomplished by the interaction between mannose 6-phosphate (Man6P) "recognition markers" on newly synthesized acid hydrolases and specific Man6P membrane receptors (reviewed in ref. 1) . The newly synthesized enzymes are believed to bind to Man6P receptors, to be removed from the biosynthetic pathway by a receptor-mediated process, and to be ferried to lysosomes via a vesicular carrier. The available evidence (2, 3) suggests that upon delivery of the enzymes to lysosomes, the enzymes dissociate from their receptors (facilitated by the low affinity of the ligand for the receptor at the acidic intralysosomal pH), and the unoccupied receptors recycle-i.e., they are carried back to the sorting site.
Recently we affinity purified the Man6P receptor and prepared monospecific anti-receptor antibodies that we used to localize the receptors by immunocytochemistry in several secretory and absorptive cell types-i.e., hepatocytes and exocrine pancreatic and epididymal epithelia (4) . We found that the receptors were concentrated in one or two of the cis cisternae of the Golgi complex, in small vesicles-often clathrin-coated-closely associated with these cisternae, and in endosomes and lysosomes. On the basis of this distribution of Man6P receptors at steady state, we proposed that normally lysosomal enzymes bearing the recognition marker are sorted, removed from the bulk of the newly synthesized proteins, and directed to endosomes and lysosomes in the cis Golgi cisternae-not in the trans cisternae of the Golgi or GERL cisternae (5) as often assumed (1, (5) (6) (7) .
In our previous experiments, Man6P receptors were localized in cells in situ that were presumably making appropriate ligands (i.e., acid hydrolases bearing the Man6P recognition marker) for the receptors, and we found that receptors were localized in Golgi cisternae, coated vesicles, endosomes, and lysosomes; we assume that these sites delineate the Man6P receptor-dependent transport pathway for newly synthesized lysosomal enzymes and that they represent the sorting site, carrier, and delivery site, respectively.
In this paper we have localized Man6P receptors in human I-cell fibroblasts from patients with mucolipidosis II-cells that have a normal complement of Man6P receptors (8) but do not make the appropriate ligand. These cells are unable to construct the recognition marker on acid hydrolases because they are deficient in one of the enzymes (N-acetylglucosaminyl phosphotransferase) required for the synthesis of the Man6P residues on oligosaccharide chains (9, 10) , and as a consequence, newly synthesized acid hydrolases are secreted into the medium, rather than being sorted intracellularly and directed to lysosomes (8) . We report here that the distribution of receptors is perturbed in these mutant ligand-deficient cells.
MATERIALS AND METHODS Materials. F(ab)2 fragments of goat anti-rabbit IgG conjugated to rhodamine were purchased from Cappel Laboratories (Cochranville, PA), and F(ab) fragments of sheep antirabbit IgG conjugated to horseradish peroxidase were from the Institut Pasteur Productions (Marnes La Coquette, France). Diaminobenzidine hydrochloride (type II) and saponin were purchased from Sigma.
Cells. Normal human foreskin fibroblasts were obtained from primary explants, and human mucolipidosis II fibroblasts (GM2273B and GM2013A) were purchased from the Human Mutant Cell Repository (Camden, NJ). Cells were grown in Eagle's minimal essential media containing 10% fetal calf serum and 1% penicillin and streptomycin, at 37°C in an atmosphere of 95% 02/5% CO2.
Antibodies to Man6P Receptor. The techniques for the preparation, characterization, and purification of monospecific rabbit antibodies to the rat liver Man6P receptor were given elsewhere (4) . The antibodies specifically precipitate only the =215-kilodalton receptor protein (11) from homogeAbbreviation: Man6P, mannose 6-phosphate.
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Cell Biology: Brown and Farquhar nates of rat liver, rat kidney, or clone 9 cells (a line of rat hepatocytes). In some preliminary experiments, antibodies to bovine Man6P receptors (kindly supplied by S. Kornfeld and G. W. Jourdian) were used, and these gave results identical to those reported below.
Immunofluorescence. Staining was performed on fixed acetone-permeabilized cultured cells as described (12) , using rabbit anti-receptor IgG followed by goat anti-rabbit IgG coupled to rhodamine. In some cases, acetone permeabilization was omitted in order to detect only surface receptors.
Immunoperoxidase. A modification of the procedures of Tougard et al. (13) and Louvard et al. (14) was used. Cells were grown to near confluency for 7 days in 35-mm Petri dishes and fixed in McClean and Nakane's fixative (15) which contained 2% (wt/vol) formaldehyde, 0.75 M lysine, and 0.01 M NaIO4 in 0.0375 M sodium phosphate buffer, pH 6.2, for 3 hr at room temperature. They were washed (four times) with phosphate-buffered saline (10 mM sodium phosphate, pH 7.4/150 mM NaCl) and then permeabilized with 0.005-0.01% saponin (16) in phosphate-buffered saline containing 0.1% ovalbumin (buffer A) for 15 min. Cells were incubated for 1 hr at room temperature in anti-Man6P receptor IgG (50 tug/ml) diluted in buffer A. After washing (five times) in buffer A, cells were incubated for 1 hr at room temperature with horseradish peroxidase-conjugated sheep antirabbit F(ab) (diluted 1:50 in buffer A), washed (five times) in buffer A and twice in phosphate-buffered saline, and fixed for 15-60 min in 1.5% (wt/vol) glutaraldehyde in 100 mM sodium cacodylate, pH 7.4, containing 5% sucrose. The cells were further washed (three times) in 100 mM sodium cacodylate, pH 7.4, containing 7.5% sucrose and once with 50 mM Tris HC1, pH 7.4, also containing 7.5% sucrose (buffer B). Peroxidase activity was visualized by incubation in diaminobenzidine medium (0.2% diaminobenzidine hydrochloride/ 0.01% H202), after which they were washed (three times) with buffer B and postfixed for 45 min at 4°C in 1% OS04 in 100 mM cacodylate buffer, reduced with 1% potassium ferrocyanide. After washing (three times) with 100 mM sodium cacodylate, pH 7.4, the cells were dehydrated in ethanol followed by rapid rinsing in 100% propylene oxide, during which they detach from the plastic dishes (17) . They were collected in a Pasteur pipette, transferred to 1.5-ml Eppendorf tubes, pelleted by centrifugation, and embedded in Epon 812 in the same tubes. Thick sections (0.5 ,um) were prepared on a Reichert Ultracut ultramicrotome and examined by light microscopy. Similarly prepared thin sections were stained with lead citrate and examined in a Philips 301 electron microscope.
RESULTS
Localization of Man6P Receptors in Normal and I-Cell Fibroblasts by Immunofluorescence. When nonpermeabilized cells were stained with affinity-purified anti-receptor IgG by indirect immunofluorescence, a diffuse, low intensity staining was seen on the surfaces of both normal (Fig. 1A ) and Icell (Fig. 1C) fibroblasts. After permeabilization, staining was observed in the juxtanuclear region of both normal and I-cell fibroblasts, but the patterns of staining were quite different. In normal fibroblasts, intracellular receptors were distributed in discrete, punctate sites located to one side of the nucleus (Fig. 1B) , whereas in I cells they were found in strands (as in Fig. 1F ), often forming a juxtanuclear reticulum (Fig. 1D ). This reticular staining pattern, which was seen in >90% of the nondividing I-cell fibroblasts, suggested that the receptors are concentrated in the Golgi region. The distribution of Man6P receptors was also investigated in normal and I-cell fibroblasts at the light microscopic level by the immunoperoxidase procedure. In such preparations, the distribution of the diaminobenzidine reaction product was similar to the immunofluorescence pattern-i.e., it formed a juxtanuclear reticulum in I cells (Fig. 1F) and a juxtanuclear punctate pattern in normal cells (not shown).
When the distribution of Man6P receptors was studied in normal human fibroblasts at the electron microscope level, a positive immunoreaction was found in Golgi cisternae, coated vesicles, and large organelles resembling lysosomes and endosomes ( Fig. 2A) . Staining was particularly intense in some, but not all, coated vesicles and in one or two Golgi cisternae. The immunoreactive Golgi cisternae were always sharply restricted to one side of the cisternal stack with no indication of a graded reactivity from one side to the other. The Golgi complexes in these cells were usually simple in structure, consisting of four to six stacked cisternal elements with associated small vesicles. In the absence of appropriate landmarks (18) such as forming secretory granules or centrioles, it was not possible to determine whether the staining was located on the cis or trans aspect of the Golgi complex. The lysosome-and endosome-like organelles containing immunoreactive receptors were not confined to the Golgi region but were found throughout the center of the cell. Often these organelles had immunoreactive coated vesicles located nearby ( Fig. 2A Inset) . In addition, reaction product occurred in a thin electron-dense layer uniformly covering the cell surface (not shown). Reaction product was absent from the rough endoplasmic reticulum, nuclear envelope, and mitochondria (Fig. 2) .
In I-cell fibroblasts (Figs. 2 B and C and 3), as in normal cells, immunoreactive receptors were highly concentrated in the Golgi region and the staining of the Golgi cisternae was restricted to one or two cisternae located on one side of the . r a * as^>,; er _.
-we K -all; \Qz -K-t- Immunoperoxidase localization of Man6P receptors by electron microscopy in normal (A) and I-cell (B and C) fibroblasts. In normal human fibroblasts, diaminobenzidine reaction product is seen primarily in two (1 and 2) cisternae located to one side of the Golgi (G) stacks, in associated coated vesicles (cv), and in larger lysosome-or endosome-like vacuoles (v). Often the coated vesicles are seen in close proximity to the reactive Golgi cisternae (1) and endosomes (see Inset). In I-cell fibroblasts (B and C), immunoreactive receptors are also found in one or two Golgi cisternae (1 and 2) and in coated vesicles (cv), but there was a striking accumulation of immunoreactive coated vesicles in the Golgi region. Often these coated vesicles are in continuity with the reactive cisternae (arrow). Not all coated vesicles (cv') contain immunoreactive receptors. C is a higher magnification of a Golgi region of another I cell, illustrating seven or eight immunoreactive coated vesicles (several are indicated by arrows) lined up along a reactive Golgi cisterna. Unlike the situation with normal fibroblasts, diaminobenzidine reaction product was absent from endosome-(v) or lysosome-like organelles in I cells. m, Mitochondria; er, rough endoplasmic reticulum. (A, x36,000; Inset, x27,000; B, x36,000; C, x60,000.) Cell Biology: Brown receptors is restricted to Golgi elements (G) which include cisternae and associated coated vesicles (arrows). Reaction product is absent from other organelles, including the rough endoplasmic reticulum (er), nucleus (n), multivesicular bodies (mv), and the large inclusions (In) characteristic of these mutant cells. Note that these inclusions, which contain clumps of electron-dense material, are typically excluded from the Golgi region. (x4800.)
stacks, whose polarity could not be determined. Moreover, in contrast to normal fibroblasts, in I cells there was a pronounced accumulation of immunoreactive coated vesicles located adjacent to the reactive Golgi cisternae; often these vesicles were lined up along this cisterna (Fig. 2C) , and a few were in continuity with it (Fig. 2B) (Fig. 3) . Another striking difference in the distribution of receptor in I cells is that staining was rarely seen in lysosomes or in electron-lucent vacuoles, presumed to be endosomes (compare Fig. 2A (Fig. 3) , as were the rough endoplasmic reticulum, nuclear envelope, and mitochondria (Figs. 2 B and C and 3).
DISCUSSION
In this report Man6P receptors for lysosomal enzymes have been localized in human fibroblasts obtained from normal subjects and from patients with mucolipidosis II. It was found that in normal fibroblasts, as in the case of cells in situ studied previously (4), receptors were highly concentrated in one or two cisternae located on one side of the Golgi stack, in endosomes and lysosomes, and in some of the clathrincoated vesicles. We assume that this distribution marks the Man6P-dependent transport pathway for newly synthesized lysosomal enzymes from the Golgi complex to lysosomes or endosomes via coated vesicles.
In I-cell fibroblasts, however, two major differences in the distribution of receptors were found: first, immunoreactive receptors were rarely observed in endosomes or lysosomes.
Second, there was a dramatic redistribution of immunoreactive coated vesicles in the mutants. In normal fibroblasts as well as in hepatocytes and exocrine pancreatic and epididymal cells (4) , receptor-bearing coated vesicles were distributed throughout the Golgi region, with some being present near the reactive Golgi cisternae and others near endosomes and lysosomes. In I cells, however, large accumulations of coated vesicles bearing the receptor were found lined up along the immunoreactive Golgi cisternae. Thus it appears that, in I cells, the immunoreactive receptors are found in increased abundance at the presumptive sorting site (Golgi cisternae) and are greatly reduced or absent along the transport pathway and at the delivery site (endosomes and lysosomes). We assume that, in the absence of the appropriate ligand, the majority of the receptors do not constitutively move along the normal delivery route from the Golgi to lysosomes; instead, they accumulate at the sorting site, where they remain awaiting, in vain, the arrival of the appropriate ligand. It must be kept in mind, however, that as has been demonstrated in the past by binding studies (1, 10) and substantiated here by immunocytochemistry, both normal and Icell fibroblasts have Man6P receptors on the cell surface.
Therefore, a mechanism must exist that is independent of Man6P-mediated triggering for the delivery of some receptors to the cell surface. How the receptors arrive at the cell surface remains to be investigated. In addition, it appears that even though the ligand is not synthesized, the receptor, an N-asparagine-linked membrane glycoprotein of the complex type (19) (20) (21) , is synthesized, targeted, and inserted by unknown means into specific Golgi cisternae and a specific subpopulation of coated vesicles that apparently function as primary lysosomes involved in the transport of lysosomal enzymes bearing the recognition marker from the Golgi complex to secondary lysosomes. Recently, Campbell and coworkers (22, 23) have isolated a coated vesicle-rich fraction from rat liver homogenates that contains Man6P receptors with bound lysosomal enzymes.
The location of the reactive Golgi cisternae-cis or trans-in the Golgi stack could not be determined in the cultured fibroblasts due to the lack of appropriate landmarks such as budding secretory granules and because both the orientation of the stacks in relation to the nucleus and their curvature are highly variable features. However, they can be tentatively identified as cis cisternae on the basis of our previous work on cells in situ (4) and in cultured clone 9 hepatocytes (24) . In such cells, which do have appropriate landmarks, the receptor was regularly localized in one or two of the cis-most Golgi cisternae, and hence, it can be considered a marker of the cis side of the Golgi stacks (4, 24 (25) (26) (27) . However, in I cells, the mannose residues of lysosomal enzymes are not phosphorylated (due to a deficiency in the transferase), and thus the lysosomal enzymes do not possess the recognition marker, do not bind to the receptors concentrated in the cis Golgi, and are not removed from the Golgi at this level. Instead, they remain in the secretory pathway and pass through the trans Golgi cisternae, where the terminal glycosyltransferases are assumed to reside (18, 28) , and their oligosaccharide chains are modified and converted in part to sialylated complex-type oligosaccharides (29) . Subsequently, they are packaged into a population of vesicles distinct from the carrier vesicles or primary lysosomes that shuttle between the Golgi and endosomes or lysosomes, and finally are discharged from these vesicles by exocytosis into the culture medium.
Our findings on the localization of Man6P receptors in I cells have several important implications of general interest in the study of membrane traffic:
(i) They suggest that, in the absence of the appropriate ligand, the coated vesicles that serve as primary lysosomes to transport acid hydrolases from the Golgi complex to endosomes and lysosomes do not constitutively shuttle between the Golgi and lysosomes or endosomes. Rather they accumulate at the presumptive sorting site-i.e., specific Golgi cisternae. Recently we have found that a similar accumulation of receptor-rich coated vesicles occurs when normal cells are made ligand deficient by treatment with the glycosylation inhibitor tunicamycin (24) . This is in contrast to receptors for low density lipoproteins (LDL), which shuttle from the cell surface to intracellular compartments and back, in the absence of exogenous LDL (30) .
(ii) They imply that in this case the movement of carrier vesicles to their delivery sites is triggered by loading of the vesicles with the appropriate ligand.
(iii) They imply that the coated vesicles that serve to ferry lysosomal enzymes to endosomes and lysosomes represent a special, stable subpopulation of such vesicles that are preprogrammed for this single mission and are not redirected or recruited for other purposes (e.g., to transport lysosomal enzymes to the plasmalemma) in the absence of the appropriate ligand. It has been clear for some time that clathrin-coated vesicles have multiple transport functions and that their specificity must be determined by their content or membrane constituents rather than by their clathrin coats (31) . Our findings on I cells imply that there is inherent specificity in the membrane composition of the primary lysosome subpopulation of carrier coated vesicles and that ligand binding leads to some modification of one or more membrane constituents that is required for their relocation to the receiving compartment.
